Determining the effectiveness of early intensive versus escalation approaches for the treatment of relapsing-remitting multiple sclerosis: The DELIVER-MS study protocol
Daniel Ontaneda, Emma Tallantyre, Praneeta Raza, Sarah M. Planchon, Kunio Nakamura, Deborah Miller, Carrie M. Hersh, Mathew Craner, Clare Bale, Burhan Chaudhry, Douglas Gunzler, Thomas E. Love, Stephen Gerry, Alasdair Coles, Jeffrey A. Cohen, Nikos Evangelou
Topics & Concepts
MedicineMultiple sclerosisMcDonald criteriaObservational studyRandomized controlled trialClinical trialClinical endpointPlaceboGlatiramer acetatePhysical therapyInternal medicineAlternative medicinePsychiatryPathologyMultiple Sclerosis Research StudiesRheumatoid Arthritis Research and TherapiesImmunotherapy and Immune Responses